NCT06296446

Brief Summary

Fibromyalgia is a syndrome characterized by chronic, generalized pain in muscles and joints with the presence of characteristic, symmetrically occurring so-called "tender points" - areas of the body that are excessively sensitive to pressure. The condition is associated with a feeling of chronic fatigue, mood and sleep disturbances and a sensation of body stiffness. These complaints are bothersome and significantly impair patients' functioning in every aspect of their lives. There are few studies evaluating the functioning and disability of people with fibromyalgia. No such study has been conducted in Poland to date. Therefore, the purpose of this study is to evaluate the functioning and disability of fibromyalgia patients and the relationship of the level of disability with selected factors, such as pain intensity, emotional state, sleep quality, etc.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 15, 2024

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

16 days

First QC Date

February 28, 2024

Last Update Submit

April 13, 2024

Conditions

Keywords

fibromyalgiadisability evaluationfunctioningWHODAS 2.0FIQBDI

Outcome Measures

Primary Outcomes (1)

  • disability

    Disability assessment using the WHO Disability Assessment Schedule. (WHODAS 2.0). The obtained results are converted on the scale from 0 to 100. When assessing the level of disability with the WHODAS 2.0, the following scale (consistent with the ICF) was used: no disability or an insufficient problem (0-4%), mild disability or a small problem (5-24%), moderate disability or a significant problem (25-49%), severe disability or a big problem (50-95%), and extreme disability or a total problem (96-100%).

    2024-01/2024-05

Secondary Outcomes (3)

  • functioning

    2024-01/2024-05

  • depression

    2024-01/2024-05

  • Sociodemographic data

    2024-01/2024-05

Study Arms (1)

people with fibromyalgia

People with fibromyalgia in Poland. The study does not include any intervention. The collected data, in a cross-sectional study, are intended to assess the functioning and disability of people with fibromyalgia using standardized questionnaires such as: WHODAS 2.0, FIQ, BDI.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adults with fibromyalgia in Poland.

You may qualify if:

  • People aged 18 and over
  • People suffering from fibromyalgia
  • People who give informed consent to participate in the study

You may not qualify if:

  • Tłumaczenie
  • Underage persons
  • People without fibromyalgia
  • People who do not give informed consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rzeszow

Rzeszów, Podkarpackie Voivodeship, 35-310, Poland

RECRUITING

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Agnieszka Sozańska

    University of Rzeszow

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnieszka Sozańska, prof.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr hab. n. o zdr., prof. UR

Study Record Dates

First Submitted

February 28, 2024

First Posted

March 6, 2024

Study Start

April 15, 2024

Primary Completion

May 1, 2024

Study Completion

November 1, 2024

Last Updated

April 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations